Electroacupuncture (EA) at Neiguan-Jianshi acupoints through an opioid mechanism inhibits the cardiovascular pressor response induced by mechanical stimulation of the stomach. Because nociceptin also may regulate cardiovascular activity through its action in the brain stem, we hypothesized that this neuromodulator serves a role in the EArelated inhibitory effect. Blood pressure (BP) in ventilated male SD rats (400-600 g)
INTRODUCTION
Recently, a novel opiate-like heptadecapeptide was identified in rat brain extracts (41; 46) . The peptide, called nociceptin (41) or Orphanin FQ (46) has a high amino acid sequence homology to classical endogenous opioid peptides (i.e., endorphins, enkephalins, endomorphins and dynorphins), and especially to dynorphin A.
Furthermore, amino acid sequencing of the receptor believed to be specific for nociceptin, ORL-1 or opioid receptor like 1, was found to be 47-50% identical to that of the coding sequences of µ-, δ-and κ-opioid receptors (10; 42; 46) . Nociceptin and ORL-1 receptors are reported to be abundantly distributed in neurons throughout the central nervous system including the rVLM, sensory trigeminal complex, raphe nuclei, locus coeruleus, periacqueductal gray, amygdala, hypothalamic and septal regions (2; 29; 30; 42; 44; 49) . These locations suggest that the nociceptinergic system may play a role in modulation of physiological activities such as regulation of pain and autonomic outflow, much like the classical endogenous opioid system.
For centuries, acupuncture has been used by Eastern cultures to treat cardiovascular diseases such as hypertension, hypotension, arrhythmias, and conditions associated with cardiac or limb ischemia. In recent years, Western society has demonstrated a heightened interest in this treatment modality. In 1993, Eisenberg et al. (22) reported that one in three individuals obtained acupuncture or another alternative therapy. A consensus conference was convened in 1997 by the National Institutes of Health to address the efficacy and biological effects of acupuncture (1) . This conference concluded that acupuncture was useful as a complementary or alternative treatment to conventional therapy for pain, nausea and vomiting and possibly for cardiovascular disease such as myocardial ischemia, arrhythmias, and hypertension. Additionally, the conference reported that acupuncture was being widely practiced by thousands of health practitioners for the management of pain and other health conditions. Although the medical community is beginning to recognize the value of acupuncture as a viable form of therapy, there is still much to be learned about its mechanisms of action.
Studies have begun to elucidate the mechanisms of acupuncture with regard to its therapeutic effects in cardiovascular disorders (5-7; 15; 24; 31; 34; 38; 47; 53) . For example, it has been suggested that the influence of electroacupuncture on the cardiovascular system is mediated, at least partially, by the release of endogenous opioid peptides, which act as neurotransmitters that modulate the activity of premotor sympathoexcitatory cells in the brain stem medulla (15; 34; 53; 54) . We previously reported that EA modulates the reflex cardiovascular response induced by chemical and electrical stimulation of visceral afferent nerves in cats (15; 33; 34; 53; 54) . In these studies, we noted that EA improves ischemic myocardial dysfunction (15; 34) by reducing demand-induced ischemia (33; 34) . These responses are mediated through inhibition of autonomic reflex responses (34) specifically through the influence of EA on cardiovascular premotor sympathetic neuronal discharge in the rVLM (53; 54; 54) . In these studies, we demonstrated that the cardiovascular effects of EA were mediated by endogenous opioids, and that an important site of action was the rVLM.
Nociceptin appears to regulate cardiovascular activity by influencing the peripheral (3; 13; 14) and central nervous systems (13; 14; 17-19) . Like classical opioids, nociceptin inhibits cardiovascular activity (18) , decreases cardiac output and total peripheral resistance (13) , and inhibits neuronal activity in the rVLM (19) . It is possible that nociceptin in the central nervous system (CNS) also contributes to the effects of EA.
Nociceptin could function through the opioid system or in parallel with opioids to evoke inhibitory cardiovascular effects of EA. At present, there is no evidence to implicate the endogenous nociceptinergic system in the rVLM in the acupuncture-induced inhibition of the cardiovascular sympathoexcitatory reflexes.
In the present study, we hypothesized that, like the opioid system, nociceptin in the rVLM modulates cardiovascular reflex responses during visceral afferent stimulation.
We further hypothesized that nociceptin works independently from the classical opioid system. To investigate these hypotheses, in a model of gastric distension-induced reflex cardiovascular excitatory responses we utilized percutaneous EA and blockade and stimulation of the classical opioid system in the rVLM before and after pharmacologic manipulation of the nociceptin system. A preliminary report on this work has been presented (20) .
METHODS

Surgical preparations
Experimental preparations and protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the University of California, Irvine, CA.
The study conformed to the American Physiological Society's "Guiding Principles for
Research Involving Animals and Human Beings" (American Physiological Society, 2002). Studies were performed on adult Sprague-Dawley male rats (400-600 g). After an 18 h overnight fast, anesthesia was induced with ketamine (100 mg/kg, im) and was followed by α-chloralose (5 mg/kg, iv). Additional doses of α-chloralose were given as necessary to maintain an adequate level of anesthesia, as determined by the lack of response to noxious toe pinch, a respiratory pattern that followed the respirator, as well as a stable blood pressure and heart rate. The right or left jugular vein was cannulated for administration of fluids. The trachea was intubated and the animals were artificially ventilated with a respirator (model 661, Harvard Apparatus). The right or left carotid artery was cannulated and attached to a pressure transducer (P23XL, Ohmeda) to monitor arterial blood pressure. Heart rate (HR) was derived from the pulsatile blood pressure signal. Arterial blood gases and pH were measured periodically with a blood gas analyzer (ABL5, Radiometer America) and were kept within normal physiological limits (PCO 2 30-40 mmHg, PO 2 >100 mmHg) by adjusting ventilatory rate or volume and enriching the inspired O 2 supply. Arterial pH was maintained between 7.35 and 7.43 by infusion of a solution of 8% sodium bicarbonate. Body temperature was kept between 36º and 38ºC with a heating pad.
A 2-cm diameter (unstressed dimension) latex balloon (Traub) was attached to a polyurethane tube (3-mm diameter) that was inserted into the stomach through the mouth and esophagus (31) . The balloon was manually palpated during insertion as it passed through the esophagus into the stomach to verify positioning of the balloon inside the stomach. A syringe was attached to the cannula to inflate and deflate the balloon with air, while a manometer through a T-connection was used to monitor balloon pressure.
Transmural pressure was determined by measuring the pressure required to inflate the balloon with the various volumes of air before it was inserted into the stomach. The balloon then was inflated inside the stomach and pressure was recorded.
Experimental Procedures
Transmural pressure was calculated as the difference in pressure of the balloon inside and outside the stomach at corresponding volumes. Volumes ranging between 6-8 ml of air were injected into the stomach of each animal, which generated transmural pressures of 11 + 1 mmHg. Injection volumes were selected to achieve transmural pressures < 20 mmHg, a value that has been reported by others to be below the pain threshold (4)in rats (52) . These distension pressures fall within the range that a rat normally experiences during ingestion of food and fluids in a single meal (21) .
Animals were placed in a stereotaxic head frame, and their heads positioned such that the floor of the fourth ventricle was horizontal. A partial occipital craniotomy was performed to expose the dorsal medulla. A three-barrel pipette (A-M Systems, Everette, WA; total outer diameter of the multibarrel tip, 45-60 µm) was inserted unilaterally (side chosen randomly) into the medulla at an angle of 90° relative to the dorsal surface of the medulla, 1.5 mm lateral from the midline, 1.8 mm rostral to the obex, and was advanced 3.2 mm from the dorsal surface toward the ventral surface. The pipette was positioned relative to the obex (interaural -4.3 mm) using landmarks as depicted in the atlas of Paxinos and Watson (45) . These coordinates provide access to a region in the rVLM that has been found by others to contain premotor sympathoexcitatory cells (25) . An injection cannula and microsyringe (Hamilton) fixed to one of the barrel of a pipette were used to administer a small dose of DL-homocysteic acid (DLH, 3-4 nM, 100nl) to identify cardiovascular pressor sites at the beginning of each experiment. Each site initially was confirmed by observing a small increase in blood pressure (5-10 mmHg) without damaging the neuron (39) . In control experiments, one of the micropipette barrels was filled with saline, while the remaining two barrels were filled with either DLH or dye.
At the end of each experiment following administration of drug into the medulla, the injection site was marked with an injection of 100 nl of Chicago Sky Blue dye (5% in 0.5 M sodium acetate). Thereafter, rats were euthanized with intravenous saturated KCl under deep anesthesia. The stomach then was exposed to verify the location of the balloon. Only animals in which the balloon was observed to be fully within the stomach were used for data analysis. The brain stem was removed and fixed in 4% paraformaldehyde and 20% sucrose for at least four days. Frozen 60 µm coronal sections were cut with a cryostat microtome (CM 1850, Leica) and then stained with 1% neutral red in acetate buffer with 2% acetic acid, pH 4.8. To confirm the injection sites histologically, dye spots were identified according to the atlas of Paxinos and Watson (1986) (45) . Diffusion distances for dye spots ranged between 80 and 100 µm.
Chemicals
All experimental drugs were purchased from Sigma Aldrich (St. Louis, MO). Drugs were dissolved in normal saline at room temperature to an initial concentration of 1 mg/ml. The stock solutions then were stored in a freezer and used within 2 weeks, after which a fresh stock solution was prepared. On the day of the experiment, appropriate serial dilutions were made to obtain desired concentrations. Concentrations of the DLhomocysteic acid (DLH) and µ-opioid agonist (DAGO) were 3-4 nM and 6-12 nM, respectively. The concentration of the final solution of nociceptin, naloxone, and nociceptin receptor antagonist was 10 nM for each 100 nl microinjection into the rVLM.
Experimental Protocols
Following the surgical procedure, we allowed a 30 to 60 minute period of stabilization before beginning the experimental protocol. Gastric distention was induced by inflating the balloon slowly within 10 s, held for an additional 10 s, and then the injected air was slowly withdrawn from the balloon. We typically noted an increase in systemic arterial blood pressure within 5-10 s following inflation. After the maximal cardiovascular pressor response, air was withdrawn from the balloon. Ten-minutes recovery intervals prevented attenuation of the cardiovascular responses (31).
Protocol 1A: Responses to repeated gastric distention. In the time control group, rats were subjected to 10 repeated periods of gastric distension without EA. The total time over which the stomach was repeatedly stimulated lasted 100 minutes.
Protocol 1B: Response to nociceptin antagonist in rVLM. We examined the effect of nociceptin antagonist on the reflex pressor responses to gastric distention.
Nociceptin was delivered unilaterally into the rVLM five minutes after the second gastric distention, followed by three more stimulations. In addition to determining the medullary influence of nociceptin in the gastric distention reflex in the absence of EA, this protocol served as a volume control for injections in the rVLM.
Protocol 2A: Response to nociceptin in rVLM. After recording two repeatable control responses to gastric distension, 0.1 µl nociceptin (10 nM) was microinjected into the rVLM, in the absence of EA, followed by an 80-minute period during which the reflex responses to gastric distension were examined repeatedly. Thus, the stomach was inflated at 10-minute intervals over a period of 100 minutes, two times before, and eight times after microinjection of nociceptin Protocol 2B: Influence of naloxone on nociceptin response. Similarl to Protocol 1, animals were instrumented to allow microinjection into the rVLM. After recording two repeatable control responses to gastric distension, naloxone (10 nM, 0.1 µl) which we have shown blocks opioid receptors (31), was microinjected unilaterally into the rVLM.
After 5 minutes, the response to gastric distension was recorded. Five minutes after gastric distension, nociceptin was microinjected at the same site in the rVLM, followed by a 70-minute period during which the reflex responses to repeated gastric distension were recorded. The control group in experiment 1B served as control for this protocol.
Protocol 3A: Influence of EA on cardiovascular response to gastric distension, microinjection of vehicle in rVLM. After recording two repeatable pre-EA control responses to gastric distension, percutaneous EA (1-2 mA, 2 Hz, 0.5-ms duration) was performed bilaterally with 32-gauge stainless steel acupuncture needles (Suzhou Medical Appliance) at the Neiguan-Jianshi acupoints (over median nerve above the paw, pericardial meridian, P 5-6) for 30 minutes in rats (16; 35) . Needles were inserted perpendicularly to a depth of 1-3 mm. Correct positioning of the needles at the acupoint was confirmed by observing slight repetitive paw twitches during stimulation, indicating stimulation of motor fibers in the median nerve (15; 31; 33). Twenty-five minutes after beginning EA, a saline injection, which functioned to control for the effects of microinjection, was administered unilaterally into the rVLM. During EA and for 50 minutes after its termination, responses to gastric distension were recorded. The 50-minute period after EA was found to be adequate for recovery from the inhibitory effects of EA on the reflex pressor response. Responses to gastric distension were induced at 10-minute intervals for a total of 100 minutes, including two before, three during and five after EA. minutes, the response to gastric distension was recorded. Five minutes later, DAGO was microinjected into the same side of the rVLM, followed by repeated gastric distensions during a 70-minute recovery period. Thus, the stomach was inflated at 10 minutes intervals over a period of 120 minutes, four times before and one time after microinjection of the nociceptin antagonist, and seven times after microinjection of DAGO.
Statistical Analysis
Data are presented as means ± standard errors of means. Delta mean arterial pressures of distension responses before, during and after EA and after delivery of saline and experimental drugs were compared by one way repeated measures of analysis of variance and post hoc by the Student-Neuman-Keuls test. All statistical analyses were performed with the software package Sigma Stat (Jandel Scientific). The 0.05 probablility level was used to determine statistically significant differences.
RESULTS
Responses to repeated Gastric Distension.
Ten repeated gastric distensions caused consistent pressor responses over a 100-minute period in six rats (Fig. 1A) . In the absence of EA, the pressor response was constant, averaging 26±1 mmHg during the duration of the protocol.
Response to nociceptin antagonist in rVLM. Microinjection of a nociceptin antagonist
did not alter the pressor responses in four rats (Fig. 1B) indicating that 100 nl of volume injection into the rVLM does not alter the reflexes and the reflex response is not mediated by nociceptin in the rVLM.
Gastric distension response to nociceptin in rVLM.
The gastric distension-induced pressor response of 19±3 mmHg was reduced to 6±2 mmHg by nociceptin administered unilaterally into the rVLM in six rats, representing a 68% change. Original blood pressure tracings are displayed in Fig. 2A 1 . Inhibition lasted for 60 minutes before returning to 15±2 mmHg, 80 minutes after microinjection of nociceptin ( Fig. 2A 2 ) .
Injection of nociceptin did not alter HR or resting blood pressure before gastric distension.
Influence of opioid antagonism on nociceptin response.
The magnitude of the pressor responses induced by gastric distension was unaltered by naloxone microinjected unilaterally into the rVLM. However, in the presence of opioid receptor blockade, nociceptin in the rVLM promptly reduced the pressor response by 64% to 8±2 mmHg (Fig. 2B ) in seven animals. Inhibition lasted for 40 minutes before returning to 22±1 mmHg 60 minutes after nociceptin. Injection of nociceptin did not change the HR responses or baseline blood pressure prior to gastric distension. Resting arterial pressure and heart rate remained constant throughout this protocol.
Effect of EA on distension of the stomach, influence of saline microinjected in rVLM.
The inhibitory effect of low-frequency EA at P 5-6 was evaluated in five animals (Fig.   3A) . Although the baseline blood pressures showed some fluctuation, blood pressures before the pressor responses were not significantly different. Heart rate also was not significantly altered during the several hours of the experiment. Before EA, the pressor responses were similar to the time control groups, averaging 22±3 and 20±4 mmHg, respectively. After 30 minutes of EA, the pressor reflex during distension of the stomach was reduced to 5±4 mmHg (75%), a response that persisted for 50 minutes after termination of EA. Microinjection of saline into the rVLM did not alter the inhibitory effect of EA.
Influence of nociceptin antagonist on EA response. EA at P 5-6 inhibited the reflex response to gastric distension from 19±2 mmHg before compared to 7±1 mmHg during EA in seven rats. Blood pressure tracings of an individual animal demonstrate the inhibitory modulation by EA of the pressor reflex as well as the effect of a nocieptin antagonist during EA (Fig. 3B 1 ) . Unilateral microinjection of a nociceptin antagonist into the rVLM immediately following EA promptly reversed the pressor response to 16±3 mmHg, a value not different than the response during the pre-EA control period, but one which was significantly higher than the response to EA before administration of the nociceptin antagonist (Fig. 3B 2 ) . Resting blood pressure and HR remained constant throughout the protocol.
Response of nociceptin antagonism to µ-opioid agonist during effect of EA. EA inhibited the reflex response to gastric distension from 21±1 to 7±1 mmHg in this group of five rats. Unilateral injection of a nociceptin antagonist into the rVLM promptly reversed the pressor response to 18±1 mmHg (Fig. 6 ). Subsequent administration of the µ-opioid agonist, DAGO, at the same site in the rVLM neutralized the antagonist's effects, noted by a prompt return of the reduced pressor response of 7±1 mmHg. This inhibition lasted change the HR responses during gastric distension. Resting mean arterial pressure and heart rate were unchanged throughout this protocol.
Location of injection sites. Examination of the rat brain slices verified that all injections located within the rVLM had significantly influenced the reflex responses to gastric distension, while five injections outside the rVLM (Fig. 4) did not alter the reflex cardiovascular responses. All effective sites for each of the protocols were confined to an area 1.00-2.50 mm rostral to the obex (interaural -4.3 mm) and the hypoglossal rootlets, 2.50-3.3 mm to the right or left of the midline, 0.1-1.7 mm from the ventral surface, lateral to the nucleus inferior olive and pyramidal tract, and ventral and medial to the facial and retrofacial nuclei and includes the medial and caudal parts of nucleus paragigantocellularis (Fig. 4) . These sites are located within the rVLM as defined previously by others (8; 25; 26; 28; 40) .
DISCUSSION
The inhibitory effect of EA on the visceral cardiovascular sympathoexcitatory pressor reflexes has been well characterized (15; 31; 34; 54) . Several studies have observed differential cardiovascular responses to gastric distention. We have developed a rodent model that yields consistent pressor responses (31) . The present study has used this model to assess the role of the novel opiate-like peptide nociceptin in the rVLM, and its contribution to electroacupuncture's inhibitory effects on the cardiovascular system. However, Feuerstein and Fadden (1982) (23) demonstrated that microinjection of an opioid peptide agonist into two hypothalamic nuclei located only 1 µm apart led to opposite effects on arterial blood pressure in the rat. Such differences in cellular response could potentially account for the previous disparate reports characterizing nociceptin's effects. More investigation will be required to determine if these mechanisms account for nociceptin's varied actions on the cardiovascular or pain systems. However, the present study provides strong evidence that nociceptin in the rVLM inhibits reflex-induced sympathoexcitatory cardiovascular responses and serves as one of the mechanisms of EA-related inhibition of excitatory pressor reflexes.
One potential limitation of this study is that the gastric distension responses in the time control group were slightly larger than the gastric distension responses observed in protocols 1B, 2A, 2B, 3A, 3B, and 3C. We suggest that this observation likely was due to the less invasive surgery in animals in the time control group compared to animals in the microinjection studies. However, it is important to note that before EA or microinjection studies, control gastric distension responses were consistent and all of the interventions were reversible. Therefore, we do not believe that differences in the control responses, vs. those in the microinjection studies, affect our conclusions. 
CONCLUSION
